Association of peroxisome proliferator-activated receptor and Hsp72.

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Janardan K. Reddy(Central Agricultural University), Keith Alvares(McMaster University), Christopher A. Bradfield(University of Wisconsin–Madison), Ruiyin Chu(Northwestern University)

Journal of Biological Chemistry

March 1, 1994

10.1016/s0021-9258(17)37221-6

Cited by 55

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

|Journal of Biological Chemistry|1993|375

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase

|Journal of Biological Chemistry|1998|342